HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norio Akuta Selected Research

Body Weight (Weight, Body)

1/2018Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2.
1/2014Utility of detection of telaprevir-resistant variants for prediction of efficacy of treatment of hepatitis C virus genotype 1 infection.
9/2013Prediction of treatment efficacy and telaprevir-resistant variants after triple therapy in patients infected with hepatitis C virus genotype 1.
10/2007Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norio Akuta Research Topics

Disease

92Hepatocellular Carcinoma (Hepatoma)
10/2023 - 01/2002
56Infections
10/2019 - 01/2002
52Chronic Hepatitis C
12/2020 - 01/2002
51Chronic Hepatitis B
10/2023 - 01/2002
46Fibrosis (Cirrhosis)
12/2023 - 01/2002
28Liver Cirrhosis (Hepatic Cirrhosis)
02/2020 - 01/2002
26Neoplasms (Cancer)
01/2023 - 01/2003
26Hepatitis
01/2014 - 01/2002
20Liver Diseases (Liver Disease)
10/2022 - 01/2002
17Chronic Hepatitis (Chronic Active Hepatitis)
03/2014 - 01/2003
16Non-alcoholic Fatty Liver Disease
07/2023 - 01/2011
15Hepatitis B
01/2022 - 01/2002
11Carcinogenesis
01/2014 - 01/2003
10Type 2 Diabetes Mellitus (MODY)
01/2022 - 03/2009
10Hepatitis C
11/2015 - 09/2005
9Liver Neoplasms (Liver Cancer)
07/2023 - 12/2010
9Diabetes Mellitus
07/2023 - 11/2008
9Anemia
10/2014 - 07/2004
5Disease Progression
09/2023 - 01/2004
5Viremia
01/2017 - 01/2007
4Insulin Resistance
01/2022 - 06/2009
4Virus Diseases (Viral Diseases)
04/2021 - 01/2004
4Body Weight (Weight, Body)
01/2018 - 10/2007
4Hypertension (High Blood Pressure)
03/2014 - 09/2009
4Persistent Infection
10/2013 - 05/2005
3Fatty Liver
04/2022 - 09/2009
3Lymphoma (Lymphomas)
12/2019 - 04/2003
3Hepatic Encephalopathy
12/2019 - 10/2004
3Thrombocytopenia (Thrombopenia)
10/2017 - 05/2009
3Liver Failure
09/2012 - 01/2004
2Proteinuria
09/2023 - 10/2022
2Autoimmune Hepatitis
10/2022 - 07/2010
2Fever (Fevers)
10/2022 - 03/2012

Drug/Important Bio-Agent (IBA)

73InterferonsIBA
12/2020 - 01/2002
38Ribavirin (Virazole)FDA LinkGeneric
01/2018 - 01/2002
35Lamivudine (Epivir)FDA Link
05/2017 - 01/2002
33Antiviral Agents (Antivirals)IBA
12/2023 - 01/2004
28RNA (Ribonucleic Acid)IBA
01/2019 - 01/2003
24Hepatitis B e AntigensIBA
03/2014 - 01/2002
23DNA (Deoxyribonucleic Acid)IBA
04/2022 - 02/2002
17Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2023 - 01/2002
15Alanine Transaminase (SGPT)IBA
03/2016 - 01/2003
13lenvatinibIBA
10/2023 - 01/2020
11entecavirFDA Link
01/2022 - 06/2007
10AntigensIBA
01/2022 - 01/2002
10alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 01/2003
10Amino AcidsFDA Link
09/2015 - 08/2008
7Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022 - 08/2008
7BilirubinIBA
10/2017 - 01/2003
7miriplatinIBA
06/2017 - 01/2011
7telaprevirIBA
10/2014 - 01/2010
6AlbuminsIBA
01/2019 - 01/2009
6Serum AlbuminIBA
10/2017 - 10/2007
6adefovir dipivoxil (Hepsera)FDA Link
06/2014 - 01/2004
6Transaminases (Aminotransferases)IBA
03/2012 - 08/2004
6Interferon-betaIBA
01/2011 - 01/2008
5Fetal Proteins (Fetoprotein)IBA
04/2021 - 09/2013
5lipoarabinomannan (LAM)IBA
05/2017 - 06/2008
5adefovirIBA
06/2014 - 01/2004
5Proteins (Proteins, Gene)FDA Link
02/2011 - 03/2006
5gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2011 - 01/2006
5Interferon-alpha (Interferon Alfa)IBA
12/2010 - 02/2002
4Hemoglobins (Hemoglobin)IBA
07/2023 - 11/2004
4Cell-Free Nucleic AcidsIBA
01/2023 - 12/2020
4Adrenal Cortex Hormones (Corticosteroids)IBA
10/2022 - 02/2002
4NucleotidesIBA
02/2022 - 09/2004
4Sodium-Glucose Transport ProteinsIBA
01/2022 - 01/2017
4SofosbuvirIBA
01/2021 - 01/2017
4Glucose (Dextrose)FDA LinkGeneric
02/2020 - 06/2012
4asunaprevirIBA
09/2018 - 03/2016
4daclatasvirIBA
09/2018 - 03/2016
4Protease Inhibitors (Protease Inhibitor)IBA
01/2017 - 01/2010
4Aspartic Acid (Aspartate)FDA Link
04/2010 - 05/2004
3Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2017
3CanagliflozinIBA
01/2022 - 05/2019
3Surface Antigens (Surface Antigen)IBA
01/2022 - 12/2002
3TransferasesIBA
04/2021 - 08/2004
3Tenofovir (Viread)FDA Link
04/2021 - 01/2014
3NucleosidesIBA
05/2017 - 06/2007
3CreatinineIBA
03/2014 - 03/2013
3Dihydrotachysterol (AT 10)IBA
01/2014 - 03/2009
3PlatinumIBA
03/2013 - 04/2009
3Methionine (L-Methionine)FDA Link
04/2010 - 05/2004
3Tyrosine (L-Tyrosine)FDA Link
04/2010 - 05/2004
2GlycolipidsIBA
09/2023 - 11/2020
2Bevacizumab (Avastin)FDA Link
09/2023 - 01/2022
2atezolizumabIBA
09/2023 - 01/2022
2Tumor Biomarkers (Tumor Markers)IBA
04/2022 - 01/2008
2tenofovir alafenamideIBA
02/2022 - 11/2021
2Circular DNAIBA
01/2022 - 01/2019
2Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022 - 08/2020

Therapy/Procedure

142Therapeutics
10/2023 - 01/2002
15Radiofrequency Ablation
02/2019 - 01/2002
7Drug Therapy (Chemotherapy)
09/2023 - 11/2011
6Drug Tapering
10/2013 - 07/2004
5Aftercare (After-Treatment)
01/2022 - 12/2006
5Retreatment
03/2019 - 04/2003
3Hepatectomy
10/2020 - 11/2017
2Precision Medicine
01/2023 - 04/2022
2Plasma Exchange
10/2022 - 10/2004